Recently, it was suggested that the growth of BRAF-mutant colon carcinoma cell lines can be inhibited by combining a BRAF inhibitor with an EGFR inhibitor, which both were suggested to be inactive as single agents [29]. This evidence concerns the gene BRAF and colon carcinoma.